Patent ID: 7041683

Claim:
A method of selectively inhibiting serotonin reuptake in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a compound of formula I wherein R 1 and R 2 are, independently, hydrogen, halogen, cyano, carboxamido, carboalkoxy of two to six carbon atoms, trifluoromethyl, alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, alkanoyloxy of 2 to 6 carbon atoms, amino, mono- or di-alkylamino in which each alkyl group has 1 to 6 carbon atoms, alkanamido of 2 to 6 carbon atoms, or alkanesulfonamido of 1 to 6 carbon atoms; or R 1 and R 2 , taken together, form methylenedioxy, ethylenedioxy or propylenedioxy; R 3 , R 4 , R 5 and R 7 are independently selected from hydrogen, halogen, cyano, trifluoromethyl, alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, alkanoyloxy of 2 to 6 carbon atoms; R 6 is hydrogen or alkyl of 1 to 6 carbon atoms; X is CR 7 or N; A dotted line represents an optional double bond; and n is an integer 0, 1 or 2; or a pharmaceutically acceptable salt thereof such that a condition selected from the group consisting of post-traumatic stress disorder, premenstrual dysphoric disorder, attention deficit disorder, obesity, eating disorders, vasomotor flushing, cocaine and alcohol addiction, and sexual dysfunction are treated.